Literature DB >> 21860406

Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma.

Zhiqing Hu1, Weihua Zhao.   

Abstract

Entities:  

Year:  2011        PMID： 21860406      PMCID： PMC4002928          DOI： 10.1038/cmi.2011.30

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

Review 1.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

Review 2.  RHO-GTPases and cancer.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 3.  Regulation and biological function of the liver-specific miR-122.

Authors:  Andrew P Lewis; Catherine L Jopling
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

4.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

5.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.

Authors:  Catharine M Sturgeon; Michael J Duffy; Barry R Hofmann; Rolf Lamerz; Herbert A Fritsche; Katja Gaarenstroom; Johannes Bonfrer; Thorsten H Ecke; H Barton Grossman; Peter Hayes; Ralf-Thorsten Hoffmann; Seth P Lerner; Florian Löhe; Johanna Louhimo; Ihor Sawczuk; Kazuhisa Taketa; Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2010-03-05       Impact factor: 8.327

Review 6.  Hereditary persistence of alpha-fetoprotein (HPAF P): review of the literature.

Authors:  A C Houwert; J C Giltay; E G W M Lentjes; M T W T Lock
Journal:  Neth J Med       Date:  2010-11       Impact factor: 1.422

7.  Downregulation of miR-122 in the rodent and human hepatocellular carcinomas.

Authors:  Huban Kutay; Shoumei Bai; Jharna Datta; Tasneem Motiwala; Igor Pogribny; Wendy Frankel; Samson T Jacob; Kalpana Ghoshal
Journal:  J Cell Biochem       Date:  2006-10-15       Impact factor: 4.429

8.  Low alpha-fetoprotein hepatocellular carcinoma.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 4.029

9.  Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver.

Authors:  Zhifang Xie; Hai Zhang; Wenwei Tsai; Ye Zhang; Yu Du; Jigen Zhong; Claude Szpirer; Minghua Zhu; Xuetao Cao; Michelle Craig Barton; Michael J Grusby; Weiping J Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

Review 10.  The multiple roles of CUX1: insights from mouse models and cell-based assays.

Authors:  Laurent Sansregret; Alain Nepveu
Journal:  Gene       Date:  2008-02-02       Impact factor: 3.688
  10 in total
  7 in total

1.  A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma.

Authors:  Chen Chen; Jiajie Hou; Zhe Lin; Ming Yao; Runqiu Jiang; Youjing Wang; Yun Gao; Qing Shao; Lei Deng; Yun Chen; Beicheng Sun
Journal:  Cell Mol Immunol       Date:  2013-05-20       Impact factor: 11.530

2.  miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase.

Authors:  Zushun Chen; Bangde Xiang; Lunan Qi; Shaoliang Zhu; Lequn Li
Journal:  Cancer Biol Ther       Date:  2020-10-06       Impact factor: 4.742

3.  HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Hua Xia; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

Review 4.  Cyclic Peptides for the Treatment of Cancers: A Review.

Authors:  Dalifa Ramadhani; Rani Maharani; Amirah Mohd Gazzali; Muchtaridi Muchtaridi
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

5.  Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.

Authors:  Yiwu Dang; Dianzhong Luo; Minhua Rong; Gang Chen
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

6.  Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.

Authors:  Minhua Rong; Gang Chen; Yiwu Dang
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

7.  DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis.

Authors:  Wenyan Li; Feng Yang; Yongxian Gui; Junjie Bian
Journal:  Oncol Lett       Date:  2014-07-15       Impact factor: 2.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.